Sinclair Pharma Plc (SPH) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Sinclair Pharma plc (Sinclair), formerly Sinclair IS Pharma plc, is an aesthetics company, which strives to provide dermatological solutions. The company develops, manufactures and distributes dermatological products for facial aesthetics, particularly for facial rejuvenation, through collagen stimulation. It offers complementary aesthetics technologies; and longer duration, natural looking and minimally-invasive treatments. It also offers dermal fillers for folds and lines. Some of Sinclairs major products include Silhouette Soft; Ellanse; Perfectha and Sculptra. It has direct sales and marketing presence in five major European countries and Brazil. It also has multi-product and multi-country distribution partnerships with several companies. Sinclair is headquartered in London, the UK.

Sinclair Pharma Plc (SPH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sinclair Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sinclair Pharma Plc, Medical Devices Deals, 2012 to YTD 2018 9
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Sinclair IS Pharma Enters Into Co-Promotion Agreement With Galderma For Kelo-cote 11
Licensing Agreements 12
Sinclair IS Pharma Enters Into Licensing Agreement With Hikma Pharma For Flammacerium 12
Sinclair IS Pharma Enters Into Licensing Agreement With Menarini Group For Three Products 13
Sinclair IS Pharma Enters Into Agreement With Biocodex For Dermatology Portfolio 14
Quintiles Enters Into Licensing Agreement With Sinclair IS Pharma 15
Equity Offering 16
Sinclair IS Pharma Announces Private Placement Of Shares For US$15 Million 16
Asset Transactions 17
Alliance Pharma Acquires Healthcare Products Business from Sinclair IS Pharma for USD198.4 Million 17
Bailleul Biorga And Hexim Pharma Acquire Non-Core Products From Sinclair IS Pharma For US$1.8 Million 18
Acquisition 19
Sinclair IS Pharma to Sell Itself 19
Sinclair Is Pharma Acquires Obvieline Labs From Pharmavital 20
Sinclair Pharma Plc - Key Competitors 21
Sinclair Pharma Plc - Key Employees 22
Sinclair Pharma Plc - Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 25
Financial Announcements 25
Apr 30, 2018: Sinclair Pharma: Preliminary results for 12 months ended 31 December 2017 25
Sep 19, 2017: Sinclair Pharma: Interim Results 28
Mar 21, 2017: Sinclair Pharma Announces Preliminary results for the 12 and 18 months ended 31 December 2016 33
Jan 17, 2017: Sinclair Pharma Announces Pre-Close Trading Update 34
Corporate Communications 35
Mar 30, 2017: Sinclair Pharma: Additional listing 35
Other Significant Developments 36
Jul 11, 2017: Sinclair Pharma: Trading Update for the 6 months to 30 June 2017 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List Of Tables

List of Tables
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sinclair Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sinclair Pharma Plc, Deals By Therapy Area, 2012 to YTD 2018 8
Sinclair Pharma Plc, Medical Devices Deals, 2012 to YTD 2018 9
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sinclair IS Pharma Enters Into Co-Promotion Agreement With Galderma For Kelo-cote 11
Sinclair IS Pharma Enters Into Licensing Agreement With Hikma Pharma For Flammacerium 12
Sinclair IS Pharma Enters Into Licensing Agreement With Menarini Group For Three Products 13
Sinclair IS Pharma Enters Into Agreement With Biocodex For Dermatology Portfolio 14
Quintiles Enters Into Licensing Agreement With Sinclair IS Pharma 15
Sinclair IS Pharma Announces Private Placement Of Shares For US$15 Million 16
Alliance Pharma Acquires Healthcare Products Business from Sinclair IS Pharma for USD198.4 Million 17
Bailleul Biorga And Hexim Pharma Acquire Non-Core Products From Sinclair IS Pharma For US$1.8 Million 18
Sinclair IS Pharma to Sell Itself 19
Sinclair Is Pharma Acquires Obvieline Labs From Pharmavital 20
Sinclair Pharma Plc, Key Competitors 21
Sinclair Pharma Plc, Key Employees 22
Sinclair Pharma Plc, Other Locations 23
Sinclair Pharma Plc, Subsidiaries 23

List Of Figures

List of Figures
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sinclair Pharma Plc, Medical Devices Deals, 2012 to YTD 2018 9

Sinclair Broadcast Group, Inc. - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Sinclair Broadcast Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Sinclair Broadcast Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes

USD 350 View Report

Sinclair Pharma Plc (SPH) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Sinclair Pharma plc (Sinclair), formerly Sinclair IS Pharma plc, is an aesthetics company, which strives to provide dermatological solutions. The company develops, manufactures and distributes dermatological products for facial aesthetics,

USD 250 View Report

Destiny Pharma Plc (DEST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Destiny Pharma Plc (Destiny Pharma), formerly Destiny Pharma Ltd, a subsidiary of Destiny Pharma Holdings Ltd is a drug development and discovery company that offers commercial exploitation and clinical development

USD 250 View Report

Midatech Pharma Plc (MTPH) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Midatech Pharma Plc (Midatech) is a pharmaceutical company that develops and commercializes products in oncology and other therapeutic areas. The companys products include gelclair, oravig, soltamox and zuplenz. It conducts

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available